Ameriprise’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48M Buy
2,825,331
+547,282
+24% +$11.7M 0.01% 893
2025
Q4
$58.5M Buy
2,278,049
+388,224
+21% +$8.93M 0.01% 796
2025
Q3
$40.7M Sell
1,889,825
-107,132
-5% -$2.43M 0.01% 1010
2025
Q2
$43.9M Buy
1,996,957
+545,431
+38% +$12M 0.01% 929
2025
Q1
$32.4M Buy
1,451,526
+1,272,622
+711% +$27.4M 0.01% 1040
2024
Q4
$3.09M Sell
178,904
-25,817
-13% -$401K ﹤0.01% 2678
2024
Q3
$3.43M Buy
204,721
+41,808
+26% +$1M ﹤0.01% 2609
2024
Q2
$4.66M Sell
162,913
-1,157
-0.7% -$34.8K ﹤0.01% 2367
2024
Q1
$6.26M Buy
164,070
+28,320
+21% +$1.07M ﹤0.01% 2192
2023
Q4
$5.05M Buy
135,750
+35,755
+36% +$1.2M ﹤0.01% 2343
2023
Q3
$3.4M Buy
99,995
+2,110
+2% +$79.7K ﹤0.01% 2558
2023
Q2
$3.85M Sell
97,885
-2,598
-3% -$93.8K ﹤0.01% 2534
2023
Q1
$3.23M Sell
100,483
-25,110
-20% -$829K ﹤0.01% 2600
2022
Q4
$3.91M Buy
125,593
+25,791
+26% +$932K ﹤0.01% 2463
2022
Q3
$3.7M Buy
99,802
+2,993
+3% +$112K ﹤0.01% 2443
2022
Q2
$2.81M Buy
96,809
+1,019
+1% +$36.5K ﹤0.01% 2655
2022
Q1
$4.92M Sell
95,790
-35,202
-27% -$1.51M ﹤0.01% 2439
2021
Q4
$6.6M Sell
130,992
-26,411
-17% -$1.48M ﹤0.01% 2275
2021
Q3
$8.81M Sell
157,403
-202,087
-56% -$11.2M ﹤0.01% 1957
2021
Q2
$21.2M Buy
359,490
+44,390
+14% +$2.49M 0.01% 1307
2021
Q1
$14M Sell
315,100
-13,221
-4% -$618K ﹤0.01% 1598
2020
Q4
$13.9M Buy
328,321
+151,238
+85% +$4.92M ﹤0.01% 1493
2020
Q3
$5.21M Buy
177,083
+45,693
+35% +$1.26M ﹤0.01% 2049
2020
Q2
$3.38M Buy
131,390
+90,429
+221% +$2.08M ﹤0.01% 2325
2020
Q1
$862K Buy
40,961
+31,649
+340% +$870K ﹤0.01% 2884
2019
Q4
$256K Buy
+9,312
New +$223K ﹤0.01% 3524

Other funds holding PGNY

Ameriprise's PGNY Position: Q1 2026 in Review

Ameriprise increased its Progyny (PGNY) stake by 24% in Q1 2026, buying an estimated $11.7M and bringing the position to 2,825,331 shares worth $48M. The position accounts for 0.01% of the portfolio, ranked #893.

Ameriprise first reported a position in PGNY in Q4 2019 and has held it in 26 quarters since. The position peaked at $58.5M in Q4 2025. 292 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Ameriprise held 2,825,331 shares of Progyny worth $48M as of Q1 2026.
  • Ameriprise bought 547,282 Progyny shares in Q1 2026, an estimated $11.7M.
  • Progyny made up 0.01% of Ameriprise's portfolio in Q1 2026, its #893 holding.
  • Ameriprise first reported a position in Progyny in Q4 2019 and has held it in 26 quarters since.
  • Ameriprise's Progyny position peaked at $58.5M in Q4 2025.
  • 292 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.